An Insertion Variant in CRH Confers an Increased Risk of Central Serous Chorioretinopathy
- PMID: 35938903
- PMCID: PMC9366725
- DOI: 10.1167/iovs.63.9.9
An Insertion Variant in CRH Confers an Increased Risk of Central Serous Chorioretinopathy
Erratum in
-
Erratum in: An Insertion Variant in CRH Confers an Increased Risk of Central Serous Chorioretinopathy.Invest Ophthalmol Vis Sci. 2022 Oct 3;63(11):17. doi: 10.1167/iovs.63.11.17. Invest Ophthalmol Vis Sci. 2022. PMID: 36264657 Free PMC article. No abstract available.
Abstract
Purpose: To identify a novel corticotropin-releasing hormone (CRH) gene variant relevant in patients with central serous chorioretinopathy (CSC).
Methods: We performed a genetic study of CSC in families and sporadic cases with controls. Using whole-exome sequencing and linkage analysis, we identified a heterozygous insertion variant, Gln52insPro, in the CRH gene that cosegregated in two Chinese families with CSC. This variant was evaluated among an additional 1307 patients with CSC and 1438 ethnicity-matched control individuals from three independent Chinese cohorts.
Results: The CRH variant was strongly associated with CSC in these cohorts of Chinese patients (Pmeta = 1.24 × 10-11; odds ratio, 3.01; 95% confidence interval, 2.15-4.21). The risk variant Gln52insPro decreased CRH gene expression.
Conclusions: Our results implicate the hypothalamic-pituitary-adrenal stress response system in the pathogenesis of CSC and provide a novel rationale for therapeutic intervention.
Conflict of interest statement
Disclosure:
Figures

Similar articles
-
Diurnal trajectories of salivary cortisol and α-amylase and psychological profiles in patients with central serous chorioretinopathy.Chronobiol Int. 2020 Apr;37(4):510-519. doi: 10.1080/07420528.2019.1702553. Epub 2019 Dec 16. Chronobiol Int. 2020. PMID: 31842621
-
Overlap of Genetic Loci for Central Serous Chorioretinopathy With Age-Related Macular Degeneration.JAMA Ophthalmol. 2023 May 1;141(5):449-457. doi: 10.1001/jamaophthalmol.2023.0706. JAMA Ophthalmol. 2023. PMID: 37079300 Free PMC article.
-
Exome sequencing in families with chronic central serous chorioretinopathy.Mol Genet Genomic Med. 2019 Apr;7(4):e00576. doi: 10.1002/mgg3.576. Epub 2019 Feb 6. Mol Genet Genomic Med. 2019. PMID: 30724488 Free PMC article.
-
The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved.Neuroendocrinology. 2011;94(1):12-20. doi: 10.1159/000328226. Epub 2011 May 13. Neuroendocrinology. 2011. PMID: 21576930 Review.
-
Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective.Endocrinol Metab Clin North Am. 1992 Dec;21(4):833-58. Endocrinol Metab Clin North Am. 1992. PMID: 1486878 Review.
Cited by
-
Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification.Taiwan J Ophthalmol. 2022 Dec 5;12(4):381-393. doi: 10.4103/2211-5056.362601. eCollection 2022 Oct-Dec. Taiwan J Ophthalmol. 2022. PMID: 36660127 Free PMC article. Review.
-
Multi-Polymorphism Analysis Reveals Joint Effects in Males With Chronic Central Serous Chorioretinopathy.Invest Ophthalmol Vis Sci. 2023 Apr 3;64(4):19. doi: 10.1167/iovs.64.4.19. Invest Ophthalmol Vis Sci. 2023. PMID: 37067365 Free PMC article.
-
Immediate Effects of Vergence Exercises Using Automatic Dual Rotational Risley Prisms on Accommodative Lag and Facility.Ophthalmol Ther. 2023 Dec;12(6):3361-3372. doi: 10.1007/s40123-023-00832-8. Epub 2023 Oct 18. Ophthalmol Ther. 2023. PMID: 37853298 Free PMC article.
References
-
- Zhao M, Zhang F, Chen Y, et al. . A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial. JAMA Ophthalmol. 2015; 133(3): 333–340. - PubMed
-
- Daruich A, Matet A, Dirani A, et al. . Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015; 48: 82–118. - PubMed
-
- Yang L, Jonas JB, Wei W.. Choroidal vessel diameter in central serous chorioretinopathy. Acta Ophthalmol. 2013; 91(5): e358–e362. - PubMed
-
- Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP.. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008; 115(1): 169–173. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources